Saturday, October 3, 2026

USD/EUR Went Down By Over 2% In The Last 21 Sessions

USD/EUR Went Down By Over 2% In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 2% for the last 21 sessions. At 09:09 EST on Thursday, 14 March, USD/EUR (USDEUR) is $0.92.

USD/EUR's yearly highs and lows, it's 3.18% up from its 52-week low and 4.378% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.07%, a negative 0.11%, and a positive 0.27%, respectively.

USD/EUR's highest amplitude of average volatility was 0.17% (last week), 0.19% (last month), and 0.27% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be oversold (<=20).

News about

  • Eur/usd price analysis: the bullish outlook remains intact above the 1.0900 mark. According to FXStreet on Tuesday, 12 March, "The EUR/USD pair gains momentum below the mid-1.0900s during the early European trading hours on Tuesday. ", " According to the four-hour chart, EUR/USD keeps the bullish vibe unchanged as the major pair is above the key 50- and 100-period Exponential Moving Averages (EMA) with an upward slope. "
  • According to FXStreet on Wednesday, 13 March, "At the time of writing, the EUR/USD pair is trading higher at 1.0927, gaining 0.01% on the day."
  • Eur/usd analysis: gains stall ahead of key US data - 12 March 2024. According to DailyForex on Tuesday, 12 March, "We tend to view the major moving averages as an indicator of where momentum is, and the EUR/USD price is sitting above the 50-, 100- and 200-day moving averages. ", "Only when the pair starts to fall below these levels will we put the EUR/USD rate on alert for a broader decline."
  • Eur/usd inches higher to near 1.0930, focus on US inflation data. According to FXStreet on Tuesday, 12 March, "A robust CPI report would likely dampen prospects of an imminent rate cut by the Federal Reserve (Fed), potentially strengthening the US Dollar (USD) and presenting challenges for the EUR/USD pair.", "The optimistic outlook surrounding the ECB could offer bolstering for the Euro, thereby supporting the EUR/USD pair. "
  • Eur/usd middled on Tuesday after mixed US CPI inflation print pins pair. According to FXStreet on Tuesday, 12 March, "The EUR/USD spent most of Tuesday cycling familiar territory, with the pair churning chart paper just north of 1.0900. ", "The EUR/USD set a fresh weekly high at 1.0980 on Monday, and the pair continues to see near-term technical support from a shortrun rising trendline."

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com